LVP software of the Ivenix Infusion System (IIS), LVP-SW-0004
FDA Device Recall #Z-1282-2024 — Class II — September 16, 2022
Recall Summary
| Recall Number | Z-1282-2024 |
| Classification | Class II — Moderate risk |
| Date Initiated | September 16, 2022 |
| Status | Completed |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Fresenius Kabi USA, LLC |
| Location | North Andover, MA |
| Product Type | Devices |
| Quantity | 3 |
Product Description
LVP software of the Ivenix Infusion System (IIS), LVP-SW-0004
Reason for Recall
Retroactively reported correction from 2022: A software defect may cause an incorrect (Fail-Stop) Alarm when an administration set is loaded with an upstream occlusion present, resulting in a non-recoverable (Fail-Stop) Pump Problem alarm. This may lead to delay of therapy, and patient may experience from no to minimal to serious harm. This issue was resolved in all fielded product in software version 5.2.1, which was installed in September 2022.
Distribution Pattern
US Nationwide distribution in the states of WI and NJ.
Lot / Code Information
UDI-DI 00811505030122 Software versions 5.0.1 and earlier.
Other Recalls from Fresenius Kabi USA, LLC
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-1048-2026 | Class II | Ivenix Infusion System (IIS), LVP Software: LVP... | Nov 21, 2025 |
| Z-0885-2026 | Class I | Ivenix Infusion System (IIS), LVP Software LVP-... | Nov 14, 2025 |
| Z-0848-2026 | Class II | Ivenix Infusion System (IIS), Large Volume Pump... | Nov 3, 2025 |
| Z-0586-2026 | Class I | IVENIX INFUSION SYSTEM, LVP Primary Administrat... | Nov 3, 2025 |
| Z-0378-2026 | Class II | Ivenix Infusion System (IIS), Large Volume Pump... | Sep 3, 2025 |
Frequently Asked Questions
A software recall means the device's embedded software or firmware has a defect that could affect its performance or safety. Many software recalls are corrected through firmware updates that can be applied without physically replacing the device. For implantable devices, the update may be delivered wirelessly during a routine clinic visit. For external devices, the manufacturer may provide updated software files or replacement units. Contact your healthcare provider to determine whether your specific device and software version are affected and what action is recommended.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.